simeprevir
Selected indexed studies
- Simeprevir. (, 2012) [PMID:31643600]
- Simeprevir. (Aust Prescr, 2015) [PMID:26648621]
- Simeprevir: first global approval. (Drugs, 2013) [PMID:24293133]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Simeprevir. (2012) pubmed
- Simeprevir. (2015) pubmed
- Simeprevir: first global approval. (2013) pubmed
- Simeprevir induces ferroptosis through β-TrCP/Nrf2/GPX4 axis in triple-negative breast cancer cells. (2024) pubmed
- Simeprevir and sofosbuvir for treatment of hepatitis C infection. (2015) pubmed
- Simeprevir: a review of its use in patients with chronic hepatitis C virus infection. (2015) pubmed
- Inhibitory effects of simeprevir on Staphylococcusepidermidis and itsbiofilm in vitro. (2023) pubmed
- Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection. (2014) pubmed
- Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection. (2015) pubmed
- Simeprevir restores the anti-Staphylococcus activity of polymyxins. (2023) pubmed